Wave Life Sciences WVE Foreign currency translation gains (losses)
Foreign currency translation gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's foreign currency translation gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's foreign currency translation gains (losses)?
- Wave Life Sciences (WVE) reported foreign currency translation gains (losses) of -$4K in Q1 2026.
- How has Wave Life Sciences's foreign currency translation gains (losses) changed year-over-year?
- Wave Life Sciences's foreign currency translation gains (losses) decreased by 106.9% year-over-year, from $58K to -$4K.
- What does foreign currency translation gains (losses) mean?
- This metric represents the net gains or losses resulting from the translation of financial statements of foreign subsidiaries from their functional currency into the reporting currency. It captures the impact of exchange rate fluctuations on the value of international assets and liabilities. Monitoring this helps investors distinguish between operational performance and volatility driven by global currency market movements.